Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

SPUTNIK V STATEMENT ON BRAZILIAN HEALTH REGULATOR ANVISA’S DECISION TO POSTPONE SPUTNIK V AUTHORIZATION IN BRAZIL:

Press release, 28.04.2021

Sputnik V authorized in Bangladesh

Press release, 27.04.2021

The Gamaleya Center statement on increasing the interval between first and second Sputnik V vaccine shots

Press release, 26.04.2021

RDIF and Viscoran İlaç agree to produce the Sputnik V vaccine in Turkey

Press release, 26.04.2021

RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt

Press release, 22.04.2021

Production of Sputnik V launched in Argentina

Press release, 20.04.2021

Sputnik V demonstrates 97.6% efficacy according to analysis of data from 3.8 million vaccinated persons in Russia making it the most efficient COVID-19 vaccine in the world

Press release, 19.04.2021

RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China

Press release, 19.04.2021

RDIF, GL Rapha and ISU ABXIS to cooperate for production of Sputnik V in Korea

Press release, 15.04.2021

Production of Sputnik V launched in Serbia

Press release, 14.04.2021

9 10 11 12 13